索宝蛋白(603231.SH):预计2025年净利润同比增长46.89%至57.62%

Core Viewpoint - The company expects significant growth in net profit for the year 2025, with projections indicating an increase of 46.89% to 57.62% compared to the previous year [1] Financial Projections - The estimated net profit attributable to shareholders for 2025 is projected to be between 178 million to 191 million yuan [1] - The estimated net profit after deducting non-recurring gains and losses is projected to be between 171 million to 182 million yuan, reflecting a year-on-year growth of 56.03% to 66.07% [1] Operational Focus - The company is concentrating on high-end manufacturing enhancement, energy optimization, and lean management as key operational strategies for 2025 [1] - Significant achievements have been made in cost reduction and efficiency improvement within production and operations [1] - The management team is closely monitoring raw material market trends to seize procurement opportunities, effectively reducing the cost of non-GMO soybean purchases [1]

Solbar Ningbo Protein Technology -索宝蛋白(603231.SH):预计2025年净利润同比增长46.89%至57.62% - Reportify